6 billion people do not have access to essential medicines for pain and palliative care when they need it. 86% of whom live in low and middle-income countries.
Despite this stark reality, amplified in the wake of the Covid-19 pandemic, access to opioid pain relief for persons suffering pain from cancer, HIV and other life limiting conditions is inadequate and fails to meet international conventions on access to essential medicines, according to the World Health Organization1